chr4-1004391-T-C

Variant summary

Our verdict is Pathogenic. The variant received 6 ACMG points: 6P and 0B. PM4PM3PM2_SupportingPP4

This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1960T>C in IDUA is a stop-loss variant, predicted to alter the stop codon (p.Ter654Arg). Sequence analysis of cDNA (by 3'RACE) showed that the variant results in an increase in the length of the protein by 38 amino acids (PMID:29282708) (PM4). Seven patients have been reported with the variant, including patients with clinical features consistent with MPS 1, and deficient IDUA activity (PMID:21394825, 29282708) (PP4). Of these patients, five are compound heterozygous for the variant and another variant in IDUA that has been classified as pathogenic by the ClinGen LD VCEP, including c.935G>A (p.Trp312Ter), phase unconfirmed (0.5 points) (PMID:29282708), c.1138C>T (p.Gln380Ter), confirmed in trans (1 point) (PMID:29282708), 46_57del12, phase not confirmed (0.5 points) (PMID:21394825), c.208C>T (p.Gln70Ter), phase not confirmed (0.5 points) (PMID:21394825), and c.266G>A (p.Arg89Gln) (PMID:29282708), phase not confirmed (0.5 points). Two patients have been reported to be homozygous for the variant (2 x 0.5 points) (PMID:29282708). Total 4 points (PM3_VeryStrong). The variant is absent in gnomAD v4.1.0. (PM2_Supporting). When expressed in COS-7 cells, the variant resulted in 6% wild type activity, and Western blot pattern was abnormal (PMID:29282708). The activity the LD VCEP's threshold for PS3_Supporting (<2%) and therefore, PS3_Supporting was not applied. Other IDUA stop loss variants have been reported in patients with MPS 1 including c.1960T>G (p.Ter654Gly) (Tieu et al, 1995, PMID:7550232), and c.1960T>A (p.Ter654Arg) (Thomas et al, PMID:33301762) and c.1962A>T (p.Ter654Cys) (Bach et al, 1993, PMID:8328452). The classification of c.1960T>C (p.Ter654Arg) will be used in the assessment of those other variants. Therefore, PM5 was not applied here to avoid circular logic. There is a ClinVar entry for this variant (Variation ID: 960079) In summary, this variant meets the criteria to be classified as pathogenic for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): PM3_VeryStrong, PM1, PM4, PP4, PM2_Supporting.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on April 7, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA355966127/MONDO:0001586/091

Frequency

Genomes: not found (cov: 32)

Consequence

IDUA
NM_000203.5 stop_lost

Scores

6

Clinical Significance

Pathogenic reviewed by expert panel P:2O:1

Conservation

PhyloP100: 0.123

Publications

8 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 6 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PM4
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
NM_000203.5
MANE Select
c.1960T>Cp.Ter654Argext*?
stop_lost
Exon 14 of 14NP_000194.2P35475-1
IDUA
NM_001363576.1
c.1564T>Cp.Ter522Argext*?
stop_lost
Exon 13 of 13NP_001350505.1
IDUA
NR_110313.1
n.2052T>C
non_coding_transcript_exon
Exon 14 of 14

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
ENST00000514224.2
TSL:2 MANE Select
c.1960T>Cp.Ter654Argext*?
stop_lost
Exon 14 of 14ENSP00000425081.2P35475-1
IDUA
ENST00000247933.9
TSL:1
c.1960T>Cp.Ter654Argext*?
stop_lost
Exon 14 of 14ENSP00000247933.4P35475-1
IDUA
ENST00000962389.1
c.2035T>Cp.Ter679Argext*?
stop_lost
Exon 15 of 15ENSP00000632448.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Mucopolysaccharidosis type 1 (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.4
DANN
Benign
0.58
Eigen
Benign
0.055
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.012
N
PhyloP100
0.12
Vest4
0.15
GERP RS
-0.75
Mutation Taster
=6/194
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906504; hg19: chr4-998179; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.